Publicacións en colaboración con investigadores/as de Instituto Ramón y Cajal de Investigación Sanitaria (5)

2024

  1. The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells

    Gut, Vol. 73, Núm. 9, pp. 1489-1508

2021

  1. Dysregulated splicing factor SF3B1 unveils a dual therapeutic vulnerability to target pancreatic cancer cells and cancer stem cells with an anti-splicing drug

    Journal of Experimental and Clinical Cancer Research, Vol. 40, Núm. 1

  2. Inhibition of mitochondrial dynamics preferentially targets pancreatic cancer cells with enhanced tumorigenic and invasive potential

    Cancers, Vol. 13, Núm. 4, pp. 1-21

2020

  1. Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells

    Nature Communications, Vol. 11, Núm. 1

  2. Modeling Cancer Using Zebrafish Xenografts: Drawbacks for Mimicking the Human Microenvironment

    Cells, Vol. 9, Núm. 9